The Whole-course Management of Pegaspargase in ENKTL
NCT05426824
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Extranodal NK/T Cell Lymphoma
Interventions
DRUG:
Pegaspargase（P-GOD）
DRUG:
Pegaspargase（PEMD）
Sponsor
The First Affiliated Hospital with Nanjing Medical University